BIDU vs CBIO · rev $18.46B vs rev $1.0M
Baidu Inc (BIDU) versus Crescent Biopharma, Inc. (CBIO) — a side-by-side from cached financials, not a winner call.
Baidu Inc (BIDU) is a internet content & information company listed on US.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
Latest reported BIDU revenue for 2025-12-31 was $18.46B. Net income was $799.0M. Revenue was up 1.2% from 2024-12-31 to 2025-12-31. BIDU currently screens at market cap $37.98B.
Latest reported CBIO revenue for 2026-06-30 was $1.0M. Net income was -$48.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. CBIO currently screens at market cap $491.3M.
BIDU currently screens at market cap $37.98B. CBIO currently screens at market cap $491.3M.
Not investment advice. Open the BIDU and CBIO stock pages for the full models.
Not investment advice.